Genome-wide association study identifies novel breast cancer susceptibility loci

By Don M. Conroy, M. Shah, Hannah Munday, C. Jordan, Barbara J. Perkins, J. West, Karen Redman, K. Driver, M. Aghmesheh, D. Amor and 115 more. 2007

2,354 citations recorded by the source corpus.

Subfields: Genetics, Molecular Biology

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. Leroy Hood
2. Zhu Chen
3. Charles Auffray

In Molecular Biology

1. Charles Auffray
2. Leroy Hood
3. Zhu Chen

Citations in the corpus

• FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer (2010, neutral): “org Downloaded from ER-positive breast cancer (34, 35).”
• Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. (2011, neutral): “02 ER(2)/PR(1) 25 110 (13) 317 (39) 275 (34) 90 (11) 27 (3) 0.”
• Systems medicine: the future of medical genomics and healthcare (2009, background): “significant problems with signal-to-noise ratios that still severely limit the conclusions that can be drawn from such studies, progress has been made in identifying susceptibility loci involved in, for example, diabetes [161-163], obesity [164], and breast or lung cancer [165-167].”
• STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement (2009, neutral): “20), as has been the situation in many recent genome-wide association studies [85, 87–105].”